TGM2 and ductal breast carcinoma in situ: This would therefore provide a possible explanation for the failed validation of the stromal TGM2 role as early sensor of transition to an invasive phenotype, since DCIS would already share the same traits of the invasive lesion and would not represent the ideal model for early stromal activation.